CLINICAL EFFICIENCY AND INFLUENCE OF COMBINED ANTIHYPERTENSIVE THERAPY UPON CYTOKINE PROFILE IN THE PATIENTS WITH ARTERIAL HYPERTENSION
Abstract. We have evaluated effects of combined anti-hypertensive therapy upon the indexes of proinflammatory cytokines and clinical aspects of chronic heart failure among the patients suffering from essential hypertension (stages II-III, high and very high risk groups). The first group (n = 45) was...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/15349f14bf264a929f709dfea89fe6e2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:15349f14bf264a929f709dfea89fe6e2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:15349f14bf264a929f709dfea89fe6e22021-11-18T08:03:38ZCLINICAL EFFICIENCY AND INFLUENCE OF COMBINED ANTIHYPERTENSIVE THERAPY UPON CYTOKINE PROFILE IN THE PATIENTS WITH ARTERIAL HYPERTENSION1563-06252313-741X10.15789/1563-0625-2009-1-49-56https://doaj.org/article/15349f14bf264a929f709dfea89fe6e22014-07-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/139https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XAbstract. We have evaluated effects of combined anti-hypertensive therapy upon the indexes of proinflammatory cytokines and clinical aspects of chronic heart failure among the patients suffering from essential hypertension (stages II-III, high and very high risk groups). The first group (n = 45) was treated with Enalapril + Hydrochlorothiazide, while the second group (n = 41) received Enalapril + Indapamide. Before starting the therapy, a pro-inflammatory cytokinemia was revealed, followed by a significant decrease of IL-6 and TNFαα levels in patients of the first group (p < 0,01), after two weeks of hospital treatment. During combined therapy, showed a sufficient decrease in systolic, diastolic and mean blood pressure levels for the both groups. A more pronounced regression of the mean blood pressure level was detected under Enalapril + Hydrochlorothiazide treatment (p < 0.002), accompanied by clinical improvement of chronic heart failure according to the clinical conditions rating scale (p < 0,001). Due to the correction of the systolic blood pressure level, all the patients showed adecrease in fatal risk of cardiovascular complications: they have left a high-risk group (5 to 10% SCORE) for a low risk group (< 5 % SCORE).T. A. DronovaD. V. PolyakovSPb RAACIarticlehypertensioncytokinescombined therapyImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 11, Iss 1, Pp 49-56 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
RU |
topic |
hypertension cytokines combined therapy Immunologic diseases. Allergy RC581-607 |
spellingShingle |
hypertension cytokines combined therapy Immunologic diseases. Allergy RC581-607 T. A. Dronova D. V. Polyakov CLINICAL EFFICIENCY AND INFLUENCE OF COMBINED ANTIHYPERTENSIVE THERAPY UPON CYTOKINE PROFILE IN THE PATIENTS WITH ARTERIAL HYPERTENSION |
description |
Abstract. We have evaluated effects of combined anti-hypertensive therapy upon the indexes of proinflammatory cytokines and clinical aspects of chronic heart failure among the patients suffering from essential hypertension (stages II-III, high and very high risk groups). The first group (n = 45) was treated with Enalapril + Hydrochlorothiazide, while the second group (n = 41) received Enalapril + Indapamide. Before starting the therapy, a pro-inflammatory cytokinemia was revealed, followed by a significant decrease of IL-6 and TNFαα levels in patients of the first group (p < 0,01), after two weeks of hospital treatment. During combined therapy, showed a sufficient decrease in systolic, diastolic and mean blood pressure levels for the both groups. A more pronounced regression of the mean blood pressure level was detected under Enalapril + Hydrochlorothiazide treatment (p < 0.002), accompanied by clinical improvement of chronic heart failure according to the clinical conditions rating scale (p < 0,001). Due to the correction of the systolic blood pressure level, all the patients showed adecrease in fatal risk of cardiovascular complications: they have left a high-risk group (5 to 10% SCORE) for a low risk group (< 5 % SCORE). |
format |
article |
author |
T. A. Dronova D. V. Polyakov |
author_facet |
T. A. Dronova D. V. Polyakov |
author_sort |
T. A. Dronova |
title |
CLINICAL EFFICIENCY AND INFLUENCE OF COMBINED ANTIHYPERTENSIVE THERAPY UPON CYTOKINE PROFILE IN THE PATIENTS WITH ARTERIAL HYPERTENSION |
title_short |
CLINICAL EFFICIENCY AND INFLUENCE OF COMBINED ANTIHYPERTENSIVE THERAPY UPON CYTOKINE PROFILE IN THE PATIENTS WITH ARTERIAL HYPERTENSION |
title_full |
CLINICAL EFFICIENCY AND INFLUENCE OF COMBINED ANTIHYPERTENSIVE THERAPY UPON CYTOKINE PROFILE IN THE PATIENTS WITH ARTERIAL HYPERTENSION |
title_fullStr |
CLINICAL EFFICIENCY AND INFLUENCE OF COMBINED ANTIHYPERTENSIVE THERAPY UPON CYTOKINE PROFILE IN THE PATIENTS WITH ARTERIAL HYPERTENSION |
title_full_unstemmed |
CLINICAL EFFICIENCY AND INFLUENCE OF COMBINED ANTIHYPERTENSIVE THERAPY UPON CYTOKINE PROFILE IN THE PATIENTS WITH ARTERIAL HYPERTENSION |
title_sort |
clinical efficiency and influence of combined antihypertensive therapy upon cytokine profile in the patients with arterial hypertension |
publisher |
SPb RAACI |
publishDate |
2014 |
url |
https://doaj.org/article/15349f14bf264a929f709dfea89fe6e2 |
work_keys_str_mv |
AT tadronova clinicalefficiencyandinfluenceofcombinedantihypertensivetherapyuponcytokineprofileinthepatientswitharterialhypertension AT dvpolyakov clinicalefficiencyandinfluenceofcombinedantihypertensivetherapyuponcytokineprofileinthepatientswitharterialhypertension |
_version_ |
1718422527049465856 |